News
Avoid anti-HER2 cancer therapies during pregnancy
- Author:
- Liam Davenport
Exposure to anti-HER2 agents was associated with “severe specific adverse pregnancy and fetal or newborn outcomes compared with exposure to other...
News
Insufficient sleep impairs women’s insulin sensitivity
- Author:
- Liam Davenport
“What we’re seeing is that more insulin is needed to normalize glucose levels in the women under conditions of sleep restriction.”
News
Does laughter offer better blood glucose control?
- Author:
- Liam Davenport
Several diabetes educators have reported that humor can encourage and support diabetes management, said Dr. David Greene.
News
Neoadjuvant, adjuvant, or both? The debate in NSCLC rages on
- Author:
- Liam Davenport
The question of whether to give upfront immunochemotherapy in resectable non–small cell lung cancer, wait until after surgery, or give both...
News
‘We finally made it’: Amivantamab comes of age in NSCLC
- Author:
- Liam Davenport
Data from three trials with amivantamab in advanced EGFR-mutant NSCLC have yielded “exciting” results with experts hailing the drug as standard of...
News
Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS
- Author:
- Liam Davenport
The study “makes me feel pretty comfortable that regardless of where you’re delivering the therapy, IV or subcutaneously, it’s getting in there...
News
Lag in antidepressant treatment response explained?
- Author:
- Liam Davenport
Compared with the placebo group, participants taking escitalopram had a marked increase in synaptic density.
News
‘Why did I choose this?’ Tackling burnout in oncology
- Author:
- Liam Davenport
Building a sustainable oncology workforce will not be easy, but improving staffing shortages and integrating resilience training can help, experts...
News
‘Frame running’ may help boost physical activity in MS
- Author:
- Liam Davenport
‘Frame running’ uses a three-wheeled frame with a saddle and body supports but no pedals to allow individuals with disabilities and balance...
News
Recombinant IL-2 shows potential in atopic dermatitis
- Author:
- Liam Davenport
Rezpegaldesleukin is now being evaluated in a phase 2b study for moderate to severe atopic dermatitis, and a phase 2b trial for alopecia areata is...
News
Chemo-immunotherapy good, adding a PARP inhibitor better in endometrial cancer?
- Author:
- Liam Davenport
Dr. Tan noted, the AtTEnd data "continue to validate practice-changing therapy for dMMR endometrial cancer patients."
News
Wearable devices show promise in monitoring multiple sclerosis
- Author:
- Liam Davenport
Further analysis may allow the prediction of “relevant changes throughout the course of multiple sclerosis.”
News
Can some patients with esophageal cancer avoid surgery?
- Author:
- Liam Davenport
About one-third of patients with esophageal cancer who have a compete response to neoadjuvant chemoradiotherapy may be able to avoid surgery....
News
Smart bracelet may predict mood changes in bipolar disorder
- Author:
- Liam Davenport
Each sensor collects a sample every second, resulting in highly detailed and granular data.
News
MS-tailored weight loss program achieves meaningful results
- Author:
- Liam Davenport
Weight loss “was associated with improved mobility, reduced fatigability, and improved physical quality of life.”